Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lalantha Leelarathna, FRCP PhD
CONTACT
Nick Oliver, FRCP PhD
CONTACT
Lead
Imperial College London
This will be a single-centre, prospective, open-label, two-stage, randomized crossover study comparing automated subcutaneous insulin delivery (AID), also known as Hybrid Closed Loop (HCL) therapy using the 780G system with usual insulin therapy plus continuous glucose monitoring (CGM) in people with type 1 and type 2 diabetes complicated by advanced renal disease and managed with insulin. The study will be conducted at Imperial College Healthcare NHS Trust. Duration of each treatment arm is 8 weeks
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted